• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand

    8/21/25 8:45:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials
    Get the next $OWLT alert in real time by email

    Certification underscores Owlet's commitment to bringing medically-certified infant monitoring technology to every family across the globe.

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ has received official certification from Australia's Therapeutic Goods Administration (TGA), meeting rigorous standards required for medical devices in the region.

    "TGA certification of Dream Sock marks an important step forward in our global expansion, bringing more families worldwide access to the latest pediatric health monitoring technology," said Jonathan Harris, Owlet's President. "For parents in these markets, certification means they will soon have access to a trusted, medically-certified tool to support their baby's health and well-being."

    Dream Sock is a wearable smart baby monitor, designed for healthy infants between 0-18 months or 2.5-13.6 kg, that tracks key health indicators such as pulse rate, oxygen level, and sleep patterns. The connected Owlet Dream App displays readings in real-time, and both the Dream App and the included Base Station provide notifications if measurements fall outside preset ranges.

    Having monitored over two million babies globally, Owlet is expanding access to its newly certified medical device to give more families peace of mind. Dream Sock is expected to be available for purchase later this year in Australia and New Zealand through the Company's local website and retail partners, including Baby Bunting. Parents can sign up at www.owletcare.com.au to be notified when Dream Sock is available and learn more about Owlet.

    About Owlet, Inc.

    Owlet's digital health infant monitoring platform is transforming the journey of parenting. The Company (NYSE:OWLT), a small-cap healthcare growth equity, offers FDA-authorized medical and consumer pediatric wearables and an integrated HD visual and audio camera that provide real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children.

    Since 2012, over two million parents worldwide have used Owlet's platform, contributing to one of the largest collections of consumer infant health and sleep data. The Company continues to develop software and digital data solutions to bridge the current healthcare gap between hospital and home and bring new insights to parents and caregivers globally. Owlet believes that every child deserves to live a long, happy, and healthy life. To learn more, visit www.owletcare.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company's certification and launch of Dream Sock™ in Australia and New Zealand, and the related impacts, growth prospects, expanded product offerings and international availability. In some cases, you can identify forward-looking statements by terms such as "estimate," "may," "believes," "plans," "expects," "anticipates," "intends," "goal," "potential," "upcoming," "outlook," "guidance," the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company's expectations at the time such statements are made, speak only as of the dates they are made and are susceptible to a number of risks, uncertainties and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company's actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company's future results and cause those results to differ materially from those expressed in or implied by the Company's forward-looking statements. Such factors include, but are not limited to, (i) the availability of, adoption and commercial success of Dream Sock in Australia, New Zealand and other international markets, (ii) the regulatory pathway for Owlet's products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA and similar regulators outside of the United States, as well as Owlet's ability to obtain and maintain regulatory approval or certification for its products and other regulatory requirements and legal proceedings; (iii) Owlet's competition and the Company's ability to profitably grow and manage growth; (iv) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (v) Owlet's ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy and data protection; (vi) Owlet's ability to maintain relationships with customers, manufacturers and suppliers; (vii) impacts from compliance with applicable laws or regulations; (viii) the impact of and disruption to Owlet's business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company's control; (ix) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (x) other risks and uncertainties set forth in the Company's other releases, public statements and filings with the U.S. Securities and Exchange Commission ("SEC"), including those identified in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and as any such factors may be updated from time to time in the Company's other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company's behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250821683058/en/

    Media Contact:

    [email protected]

    Investor Contact:

    [email protected]

    Get the next $OWLT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OWLT

    DatePrice TargetRatingAnalyst
    4/23/2025$7.00Outperform
    Northland Capital
    10/6/2021$12.00 → $5.00Neutral
    Citigroup
    10/5/2021$8.50 → $5.50Buy → Neutral
    BofA Securities
    9/8/2021$8.50Buy
    BofA Securities
    8/5/2021$11.00Neutral
    Citigroup
    More analyst ratings

    $OWLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand

    Certification underscores Owlet's commitment to bringing medically-certified infant monitoring technology to every family across the globe. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ has received official certification from Australia's Therapeutic Goods Administration (TGA), meeting rigorous standards required for medical devices in the region. "TGA certification of Dream Sock marks an important step forward in our global expansion, bringing more families worldwide access to the latest pediatric health monitoring technology," said Jonathan Harris, Owlet's President. "For parents in these markets, certifica

    8/21/25 8:45:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Reports Second Quarter 2025 Financial Results; Increases Full Year 2025 Guidance; Announces CEO Transition Plan

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w

    8/7/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet to Simplify Capital Structure Through Exchange of Series A and Series B Warrants for Common Stock

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced an agreement with a majority of the holders of the Company's Series A and Series B warrants to exchange their warrants for common stock. "We're very pleased to simplify our capital structure through today's announced warrant exchange," said Jonathan Harris, Owlet's President. "The successful exchange of these warrants will be an important milestone that we believe improves the attractiveness of our stock, strengthens our capital structure, and supports the long-term success of the business." As a part of the exchange, the Company will issue an aggregate of 5,426,429 shares of comm

    8/7/25 4:01:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    SEC Filings

    View All

    Amendment: Owlet Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

    8-K/A - Owlet, Inc. (0001816708) (Filer)

    8/13/25 4:45:01 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by Owlet Inc.

    10-Q - Owlet, Inc. (0001816708) (Filer)

    8/8/25 4:25:13 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form DEFA14A filed by Owlet Inc.

    DEFA14A - Owlet, Inc. (0001816708) (Filer)

    8/7/25 5:01:17 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Owlet with a new price target

    Northland Capital initiated coverage of Owlet with a rating of Outperform and set a new price target of $7.00

    4/23/25 9:11:45 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Citigroup reiterated coverage on Owlet with a new price target

    Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously

    10/6/21 12:45:24 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet downgraded by BofA Securities with a new price target

    BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously

    10/5/21 7:41:47 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Harris Jonathan sold $56,606 worth of shares (14,170 units at $3.99), decreasing direct ownership by 5% to 266,707 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    5/21/25 9:15:54 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Crawford Amanda sold $783 worth of shares (182 units at $4.30), decreasing direct ownership by 0.12% to 150,508 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    1/21/25 9:30:13 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    President & CRO Harris Jonathan sold $106,436 worth of shares (24,179 units at $4.40), decreasing direct ownership by 8% to 280,877 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    1/21/25 9:24:43 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Leadership Updates

    Live Leadership Updates

    View All

    Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m

    10/2/23 8:30:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Eclipse Partner Marc Stoll to Board of Directors

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome

    8/16/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

    Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'

    7/19/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Owlet Inc.

    SC 13G/A - Owlet, Inc. (0001816708) (Subject)

    10/24/24 4:05:58 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 6:39:55 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 4:25:26 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Financials

    Live finance-specific insights

    View All

    Owlet Reports Second Quarter 2025 Financial Results; Increases Full Year 2025 Guidance; Announces CEO Transition Plan

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w

    8/7/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet to Report Second Quarter 2025 Financial Results on August 7, 2025

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT) plans to announce second quarter 2025 financial results after market close on Thursday, August 7, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 579904. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay will be available

    7/24/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Announces First Quarter 2025 Financial Results

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, May 8, 2025, at 4:30 p.m. ET. Q1 2025 Financial Highlights: Q1 Revenue of $21.1 million, up 43.1% from Q1 2024 Q1 Gross Margin of 53.7%, up 930 basis points from Q1 2024 Q1 Net Income of $3.0 million, compared to $3.3 million in Q1 2024 Q1 Adjusted EBITDA of $0.0 million, improving

    5/8/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials